The best value stocks right now, ranked.
Ticker Nerd's model re-ranks roughly 4,600 US stocks every trading day, and the 1,500 big and liquid enough to trade are eligible here. These 25 score highest on its Value factor right now. What the shares cost against the profits, cash flow and assets standing behind them.
Every score is a percentile across the whole US universe we cover — a 92 beats 92% of it. How the model was built and blind-tested is on the methodology page; what each factor means is on the factor glossary.
| Ticker | Company | Mkt cap | Rank | 1w rank Δ | Revisions | Value | Momentum | Quality | Accruals | Issuance | Growth | Volatility | Size |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb Co. Drug Manufacturers - General | $128.4B | 99.5 | +0.2 | 98.1 | 99.8 | 86.7 | 92.1 | 65.1 | 93.2 | 67.0 | 99.7 | 2.0 | |
KBR, Inc. Engineering & Construction | $4.5B | 74.2 | −0.8 | 65.0 | 99.7 | 26.9 | 82.7 | 48.2 | 89.6 | 34.3 | 95.2 | 24.6 | |
Leidos Holdings, Inc. Information Technology Services | $16.0B | 63.7 | +0.2 | 69.1 | 99.7 | 19.7 | 95.8 | 56.2 | 54.9 | 32.1 | 78.6 | 11.3 | |
Blue Owl Technology Finance Corp Asset Management | $4.9B | 52.7 | 0.0 | 78.7 | 99.7 | 34.3 | 70.3 | 16.6 | 23.3 | 54.2 | 74.0 | 23.4 | |
Harmony Biosciences Holdings, Inc. Biotechnology | $2.4B | 85.5 | +1.0 | 78.1 | 99.7 | 63.4 | 83.2 | 47.5 | 51.8 | 52.9 | 81.3 | 33.0 | |
Exelixis, Inc. Biotechnology | $15.2B | 98.0 | +0.2 | 53.9 | 99.6 | 83.5 | 98.1 | 82.3 | 95.0 | 73.9 | 96.5 | 11.8 | |
Booz Allen Hamilton Holding Corp. Consulting Services | $9.3B | 70.0 | +0.5 | 62.9 | 99.5 | 17.8 | 94.5 | 61.6 | 89.4 | 18.5 | 87.9 | 16.0 | |
Constellium SE Aluminum | $3.5B | 98.4 | 0.0 | 89.2 | 99.5 | 80.5 | 92.5 | 26.0 | 97.6 | 98.7 | 47.2 | 27.9 | |
Sarepta Therapeutics, Inc. Biotechnology | $2.1B | 70.8 | −0.2 | 46.6 | 99.4 | 33.5 | 80.6 | 93.1 | 76.3 | 27.9 | 44.1 | 34.9 | |
ADMA Biologics, Inc. Biotechnology | $2.0B | 43.5 | +0.7 | 42.5 | 99.3 | 7.9 | 99.4 | 17.7 | 41.2 | 46.6 | 70.1 | 35.2 | |
HP, Inc. Computer Hardware | $31.5B | 95.6 | −0.6 | 97.6 | 99.3 | 57.4 | 71.9 | 57.0 | 93.7 | 63.4 | 97.3 | 7.4 | |
Merck & Co., Inc. Drug Manufacturers - General | $364.5B | 83.1 | +1.0 | 61.9 | 99.2 | 88.4 | 98.7 | 71.9 | 41.5 | 37.9 | 99.8 | 0.6 | |
Science Applications International Corp. Information Technology Services | $5.8B | 91.2 | +0.4 | 90.5 | 99.2 | 63.5 | 84.5 | 64.3 | 64.8 | 35.9 | 92.3 | 21.1 | |
Cirrus Logic, Inc. Semiconductors | $6.1B | 85.6 | −0.5 | 51.3 | 99.2 | 42.5 | 94.2 | 65.1 | 88.9 | 53.6 | 97.8 | 20.3 | |
Gilead Sciences, Inc. Drug Manufacturers - General | $186.3B | 93.8 | +1.1 | 73.8 | 99.2 | 73.8 | 95.9 | 97.7 | 50.1 | 52.0 | 99.6 | 1.4 | |
United Therapeutics Corp. Drug Manufacturers - Specialty & Generic | $21.0B | 81.3 | −0.3 | 37.8 | 99.1 | 74.2 | 90.7 | 64.1 | 86.8 | 44.6 | 98.6 | 9.7 | |
Biogen, Inc. Drug Manufacturers - General | $31.6B | 74.9 | −0.1 | 61.0 | 99.1 | 86.7 | 85.7 | 62.0 | 32.0 | 39.0 | 98.5 | 7.4 | |
Kinross Gold Corp. Gold | $33.3B | 88.4 | +0.1 | 34.6 | 99.0 | 61.6 | 99.5 | 46.7 | 96.5 | 94.2 | 92.2 | 7.0 | |
Jefferies Financial Group, Inc. Capital Markets | $11.0B | 62.5 | +3.2 | 51.7 | 99.0 | 46.7 | 74.7 | 15.5 | 60.4 | 85.0 | 71.7 | 14.4 | |
Vontier Corp. Scientific & Technical Instruments | $4.4B | 82.3 | −3.1 | 80.5 | 98.9 | 15.0 | 74.6 | 70.5 | 99.1 | 45.1 | 59.7 | 24.8 | |
Aurinia Pharmaceuticals, Inc. Biotechnology | $2.2B | 93.7 | +0.5 | 54.4 | 98.9 | 75.5 | 96.6 | 21.9 | 91.5 | 81.5 | 98.0 | 33.9 | |
Macy's, Inc. Department Stores | $5.8B | 96.1 | −0.1 | 73.1 | 98.9 | 89.8 | 53.6 | 83.5 | 95.6 | 79.3 | 36.8 | 21.1 | |
Halozyme Therapeutics, Inc. Biotechnology | $12.8B | 97.6 | +0.4 | 90.4 | 98.8 | 92.2 | 98.8 | 66.1 | 45.3 | 67.7 | 97.6 | 13.0 | |
Bausch Health Cos., Inc. Drug Manufacturers - Specialty & Generic | $2.1B | 96.1 | −0.4 | 74.6 | 98.7 | 42.8 | 86.6 | 94.6 | 82.1 | 67.2 | 62.6 | 35.0 | |
PHINIA, Inc. Auto Parts | $2.3B | 85.9 | −1.3 | 42.0 | 98.7 | 69.3 | 57.9 | 76.7 | 79.4 | 77.3 | 71.9 | 33.5 |
Today’s snapshot only — the list rotates as the scores move. Click any ticker for its full page: rank against every factor, analyst price targets, financials and news.
What these value stocks look like up close.
Figures for the 25 listed names, from the same data behind their stock pages.
14 of the 25 names with analyst coverage this month carry a Buy-or-better majority.
Cheapest on trailing P/E: CSTM at 6.7×, AUPH at 7.4× and M at 8.0×.
Highest forward dividend yields: BMY at 4.0%, M at 3.5% and HPQ at 3.5%.
Where we've written the stock up.
An analyst-style read on the business behind the score — published on the stock page.
This page is one list. Monday covers the whole market.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks and the factor behind each one. The names above will rotate as the scores move — the Radar is how you hear what changed.
Questions people ask about value stocks.
- What are the best value stocks right now?
- As at 19 Sept 2026, the top-ranked value stocks on Ticker Nerd's systematic factor model are Bristol Myers Squibb Co. (BMY), KBR, Inc. (KBR), Leidos Holdings, Inc. (LDOS). The full top 25 is the table on this page, re-ranked every trading day. A rank is general information, not personal advice.
- How does Ticker Nerd pick the best value stocks?
- Nobody picks them. A factor model scores roughly 4,600 US stocks every trading day on families like value, momentum, quality and growth, and this page is one fixed cut of that ranking. The research process behind the model — point-in-time data from 2005, locked test windows, logged rejections — is published on the methodology page.
- Are value stocks a good investment?
- That depends on the price paid and on your circumstances — this page is general information, not advice. What the data says as at 19 Sept 2026: of the 25 listed names with analyst coverage this month, 14 carry a Buy-or-better majority, and every rank above is a percentile across roughly 4,600 US stocks.
The same model, other cuts.
Every list reads the one ranking — the stock screener index has the complete set.